| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand | Rinvoq, fka ABT-494 | |
| 3 | Generic | upadacitinib | |
| 4 | MOA | JAK1 selective | |
| 5 | Indication | ||
| 6 | Crohn's Phase III | ||
| 7 | GCA Phase III | ||
| 8 | Rheumatoid Arthritis approved (US, EU) | ||
| 9 | Ulcerative Colitis approved (US, EU) | ||
| 10 | PsA approved (US, EU) | ||
| 11 | |||
| 12 | SELECT-COMPARE | ||
| 13 | SELECT-CHOICE | ||
| 14 | SELET-AXIS 2 | ||
| 15 | Phase III "U-ACHIEVE" UC | ||
| 16 | Phase III "U-EXCEL" UC |